Definitive Contract HDTRA125C0007

Award Date 2/25/25
Potential Completion Date 2/25/27
Potential Value $1.1M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Herndon, VA 20190, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
This is a $999,999.15 Firm Fixed Price definitive contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Parabon Nanolabs, Inc., a small business, for a Phase II Small Business Innovation Research (SBIR) project. The contract has a total small business set-aside designation. The award supports continued research and development on novel DNA nanotechnology and engineering systems for applications such as gene therapy, vaccines, drug delivery, and genome...
The U.S. Defense Threat Reduction Agency (DTRA) awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Parabon Nanolabs, Inc. valued at $167,458. The contract is for the development of the "KIN-X" software system, which is designed to enable rapid and distant kinship inference and automated pedigree reconstruction. This is a firm-fixed-price purchase order contract with a performance period ending on October 14, 2021. Parabon Nanolabs is a for-profit company...
This is a $999,996.51 Firm Fixed Price definitive contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Parabon NanoLabs, Inc. under the Small Business Innovation Research (SBIR) Phase II program. The contract is for research and development work related to engineering DNA for next-generation nanotech, analytics, and forensics applications. As a Total Small Business set-aside contract, it is intended to support innovative small business research. Parabon...
This is a $1,100,000.00 Small Business Innovation Research (SBIR) Phase II contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Parabon Nanolabs, Inc. The contract is for "Origami Antibodies for Threat Sensing", which involves research and development of novel systems leveraging DNA nanotechnology for applications such as sensing, vaccines, drug delivery, and gene therapy. Parabon Nanolabs is a company that specializes in engineering DNA for...
This federal contract award W911SR20C0043, in the amount of $1,099,958.56, was issued by the U.S. Army Research, Development and Engineering Command (RDECOM) to Parabon Nanolabs, Inc., a small business, for the design of software for DNA-based sensing nano-architectures under the Small Business Innovation Research (SBIR) program. The contract has a total small business set-aside designation and a performance period ending on August 27, 2023. Parabon Nanolabs specializes in DNA engineering and...
This is a federal contract award from the Washington Headquarters Service, a Defense agency, to Parabon Nanolabs, Inc., a for-profit company based in Reston, Virginia. The contract, valued at $3,179,660.26, is for scientific research services under a STTR Phase III research type. The contract is a definitive contract with a cost plus fixed fee pricing type, and the performance period extends to June 20, 2021. This contract does not have a set-aside designation. Parabon Nanolabs specializes in...
<p>This is a $1,387,564.38 firm fixed-price SBIR Phase II contract awarded by the Defense Threat Reduction Agency (DTRA) to Paratus Diagnostics, LLC, a small business. The contract is for establishing the PrepareNOW system as an open-architecture platform for identifying biowarfare agents from swab samples. The work will be performed in San Marcos, TX and the contract has a completion date of June 17, 2022.</p>
This is a $149,877.00 firm fixed price purchase order awarded by the Defense Threat Reduction Agency (DTRA) to Radiant Genomics, Inc., a small disadvantaged business. The contract is for a SBIR Phase I research project. SBIR stands for Small Business Innovation Research, which is a program that provides funding for small businesses to conduct research and development. The contract has a total small business set-aside, meaning it was reserved for small businesses. The period of performance ends...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Threat Reduction Agency (DTRA), a defense agency, to Arzeda Corp for the &quot;Computational Design of Enzymatic Prophylactics and/or Therapeutics for Chemical Warfare Nerve Agents.&quot; The contract has a ceiling value of $1,118,433.12 and a period of performance through February 28, 2025. As an SBIR Phase II award, this contract continues the development of technologies originally researched under a...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Threat Reduction Agency (DTRA), a Defense agency, to 4S - Silversword Software &amp; Services, LLC, a minority-owned small disadvantaged business certified in the SBA's 8(a) program. The $167,490.79 firm-fixed-price contract is for the &quot;SILVERSWORD NUCLEOTIDE SEQUENCING&quot; research and development project, with a performance period ending on May 20, 2025. As an SBIR Phase I award, this contract...

This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Threat Reduction Agency (DTRA), a component of the U.S. Department of Defense, to Parabon Nanolabs, Inc. The $1,099,912 firm-fixed-price contract is for the development of a system to engineer nanocarriers capable of transporting cargo across the blood-brain barrier. The contract has a total small business set-aside designation and is scheduled for completion by February 25, 2027. Parabon Nanolabs is a company that specializes in engineering DNA for various nanotechnology applications, and has previously received federal contract awards and grants for research and development in areas like gene therapy, vaccines, and drug delivery.

Generated 5/27/25, 10:00 AM